Kim CT, et al. - Researchers herein focused on the efficacy and safety of the programmatic use of bedaquiline and delamanid in multidrug-resistant tuberculosis (MDR-TB) treatment. Findings demonstrated safety as well efficacy of bedaquiline and delamanid as treatment options for MDR-TB. Furthermore, when an adequate treatment regimen could not be constructed, sequential administration of these two drugs was considered a viable treatment strategy for patients, as indicated by the initial evidence found in this study.